semaglutide tirzepatide weight loss mechanism How Does Work? Unveiling the Multifaceted Benefits of

Real-world evidence (Nature, 2023) A survey of 153 adults with obesity who were already taking semaglutide or tirzepatide found they reported a 73% reduction in weekly alcohol consumption, and their likelihood of binge-drinking dropped by about 80% compared to similar people not on medication

Individual results vary depending on starting weight, dose, lifestyle, and duration of treatment

Important Notice These statements have not been evaluated by the FDA

People with a history of allergies, eczema, or prior drug rashes may be more likely to develop these side effects, although evidence is still limited

Shots start daily or weekly